Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2004
11/25/2004US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004US20040235798 Identifying a small organic molecule having a core structure, the small organic molecule having a cytotoxic antifungal activity; andpreparing a compound comprising the core structure of the identified cytotoxic antifungal agent
11/25/2004US20040235753 Oxytocin agonists
11/25/2004US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004US20040234958 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
11/25/2004CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004CA2524706A1 Synthesis of substituted heterocyclic compounds
11/24/2004EP1479671A1 Pyrimidinone compounds
11/24/2004EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004EP1478644A1 Substituted 4-pyrazolyl pyrazolines used for pest control
11/24/2004EP1478634A1 Furanone derivatives
11/24/2004EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004EP1478364A2 Selective antibacterial agents
11/24/2004EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004EP1109550B1 Novel nitrophenylaziridine compounds and their use as prodrugs
11/24/2004EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators
11/24/2004CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/23/2004US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004US6821977 Antidiabetic agents
11/23/2004US6821966 Antiinflammatory agents
11/23/2004US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004WO2004099201A1 Compounds as crf1 receptor antagonists
11/18/2004WO2004099190A1 Novel substituted benzimidazole derivatives
11/18/2004WO2004099189A1 Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists
11/18/2004WO2004099188A1 Antitumoral antiadrogenic pyrrolidines
11/18/2004WO2004099185A1 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors
11/18/2004WO2004099177A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004WO2004099161A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004WO2004099157A1 Cannabinoid receptor ligands and uses thereof
11/18/2004WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004WO2004099155A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004WO2004099146A1 Benzamide inhibitors of the p2x7 receptor
11/18/2004WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004WO2004099131A2 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004WO2004098610A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004WO2004098609A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004WO2004098602A1 Melanocortin receptor-specific compounds
11/18/2004WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004WO2004098528A2 Pyrazole-amine compounds useful as kinase inhibitors
11/18/2004WO2004098518A2 Pyrazole-amide compounds useful as kinase inhibitors
11/18/2004WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004US20040229909 Antiviral agent
11/18/2004US20040229892 HIV integrase inhibitors
11/18/2004US20040229891 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
11/18/2004US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004CA2531869A1 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004CA2525195A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004CA2524622A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004CA2524519A1 Compounds as crf1 receptor antagonists
11/18/2004CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004CA2524318A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/17/2004EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004EP1477482A1 Novel phenylalanine derivative
11/17/2004EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004EP1477186A1 Antipruritics
11/17/2004EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004EP1476443A2 Process for preparing indolinone derivatives
11/17/2004EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004EP0888338B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) 1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
11/17/2004CN1547580A CCR5 antagonists useful for treating aids